Edwards Lifesciences Corporation (EW)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Bernard J. Zovighian
|
CEO & Director | 3.79M | 1.06M | 1968 |
|
Mr. Donald E. Bobo Jr.
|
Corporate Vice President of Strategy & Corporate Development | 1.6M | 1.04M | 1962 |
|
Mr. Daveen Chopra
|
Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies | 1.56M | -- | 1979 |
|
Ms. Annette Maria Bruls
|
Corporate Vice President of EMEA, Canada, & Latin America | 1.63M | -- | 1971 |
|
Ms. Theodora Mistras
|
Corporate VP & CFO | -- | -- | 1982 |
|
Mr. Joseph Nuzzolese
|
Corporate Vice President of Global Operations & Quality | -- | -- | -- |
|
Mr. Andrew M. Dahl
|
Principal Accounting Officer, Senior VP & Corporate Controller | -- | -- | 1978 |
|
Dr. Todd Brinton FACC, M.D.
|
Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer | -- | -- | -- |
|
Mr. Snehashish Sarkar
|
Senior VP and Chief Information & Digital Officer | -- | -- | 1975 |
|
Mr. Mark D. Peterson
|
Corporate VP & General Counsel | -- | -- | 1963 |
Edwards Lifesciences Corporation
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 16,000
Description
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Corporate Governance
Upcoming Events
November 4, 2026 at 8:00 PM UTC
Edwards Lifesciences Corporation Earnings Date
Recent Events
May 27, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
